Table 1.
Subject Characteristics According to Coronary Artery Calcification Score Under or Above 100
| All Subjects N = 3408, no. (%) | Subjects With CAC Score ≤100, n = 2884, no. (%) | Subjects With CAC Score >100, n = 524, no. (%) | P | |
|---|---|---|---|---|
| Age, y | ||||
| >50 | 2003 (58.8) | 1552 (53.8) | 451 (86.1) | |
| ≤50 | 1405 (41.2) | 1332 (46.2) | 73 (13.9) | <0.001 |
| Overweight | 1439 (42.2) | 1200 (41.6) | 239 (45.6) | 0.088 |
| Diabetes mellitus | 397 (11.6) | 286 (9.9) | 111 (21.2) | <0.001 |
| Hypertension | 1269 (37.2) | 970 (33.6) | 299 (57.1) | <0.001 |
| Hypercholesterolemia | 786 (23.1) | 586 (20.3) | 200 (38.2) | <0.001 |
| Hypertriglyceridemia | 514 (15.1) | 434 (15.0) | 80 (15.3) | 0.898 |
| Low HDL cholesterolemia | 239 (7.0) | 197 (6.8) | 42 (8.0) | 0.329 |
| Metabolic syndrome | 455 (13.4) | 350 (12.1) | 105 (20.0) | <0.001 |
| Abnormal liver function | 1024 (30.0) | 857 (29.7) | 167 (31.9) | 0.322 |
| hsCRP (mg/dL) | ||||
| <0.1 | 2370 (69.5) | 2031 (70.4) | 339 (64.7) | |
| 0.1–0.3 | 794 (23.3) | 655 (22.7) | 139 (26.5) | |
| >0.3 | 244 (7.2) | 198 (6.9) | 46 (8.8) | 0.028 |
| Elevated SUA (mg/dL) | 389 (11.4) | 336 (11.7) | 53 (10.1) | 0.309 |
| Serum creatinine (mg/dL) | ||||
| <0.7 | 39 (1.2) | 34 (1.2) | 5 (1.0) | |
| 0.7–1.3 | 3324 (97.5) | 2815 (97.6) | 509 (97.1) | |
| 1.4–2.0 | 45 (1.3) | 35 (1.2) | 10 (1.9) | 0.401 |
| Current smoker | 975 (28.6) | 753 (26.1) | 222 (42.2) | <0.001 |
| Statin treatment | 48 (1.4) | 40 (1.4) | 8 (1.5) | 0.178 |
Abbreviations: CAC, coronary artery calcification; HDL, high‐density lipoprotein; hsCRP, high‐sensitivity C‐reactive protein; SUA, serum uric acid. χ 2 analysis was applied for comparison among groups. P < 0.05 was considered significant.